COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,435 Articles (22,835 medRxiv, 8,600 bioRxiv)

Most recent first Previous |  Page 1717: Articles 17161-17170  | Next

Accuracy of Computable Phenotyping Approaches for SARS-CoV-2 Infection and COVID-19 Hospitalizations from the Electronic Health Record
Khera, R., Mortazavi, B., Sangha, V., Warner, F., Young, H. P., Ross, J. S., Shah, N. D., Pollock, B. D., Wang, K., Brandt, C. A., Lin, Z., Krumholz, H. M., Schulz, W. L.
10.1101/2021.03.16.21253770 — Posted: 2021-03-20
Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena Valley
Melotti, R., Scaggiante, F., Falciani, M., Weichenberger, C. X., Foco, L., Lombardo, S., De Grandi, A., von Laer, D., Mahlknecht, A., Pramstaller, P. P., Pagani, E., Meier, H., Gaertner, T., Troi, C., Mascalzoni, D., Pattaro, C., Mian, M.
10.1101/2021.03.19.21253883 — Posted: 2021-03-20
A convergence based assessment of relative differences in age-stratified susceptibility and infectiousness for SARS-CoV-2 variants of B.1.1.7 lineage
Rasmussen, S. D.
10.1101/2021.03.18.21253931 — Posted: 2021-03-20
Data-driven estimate of SARS-CoV-2 herd immunity threshold in populations with individual contact pattern variations
Lu, D., Aleta, A., Ajelli, M., Pastor-Satorras, R., Vespignani, A., Moreno, Y.
10.1101/2021.03.19.21253974 — Posted: 2021-03-20
Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study Design
Oelsner, E. C., Allen, N. B., Ali, T., Anugu, P., Andrews, H., Asaro, A., Balte, P. P., Barr, R. G., Bertoni, A., Bon, J., Boyle, R., Chang, A. A., Chen, G., Cole, S. A., Coresh, J., Cornell, E., Correa, A., Couper, D., Cushman, M., Demmer, R. T., Elkind, M. S., Folsom, A. R., Fretts, A. M., Gabriel, K. P., Gallo, L., Gutierrez Contreras, J., Han, M. K., Henderson, J. M., Howard, V. J., Isasi, C. R., Jacobs, D. R., Judd, S. E., Kamin Mukaz, D., Kanaya, A. M., Kandula, N. R., Kaplan, R. C., Krishnaswamy, A., Kinney, G. L., Kucharska-Newton, A., Lee, J. S., Lewis, C. E., Levine, D. A., Levitan, E. B., Levy, B., Make, B., Malloy, K., Manly, J. J., Meyer, K. A., Min, Y.-I., Moll, M., Moore, W. C., Mauger, D., Ortega, V. E., Palta, P., Parker, M. M., Phipatanakul, W., Post, W., Psaty, B. M., Regan, E. A., Ring, K., Roger, V. L., Rotter, J. I., Rundek, T., Sacco, R. L., Schembri, M., Schwartz, D. A., Seshadri, S., Shikany, J. M., Sims, M., Stukovsky, K. D. H., Talavera, G. A., Tracy, R. P., Umans, J. G., Vasan, R. S., Watson, K., Wenzel, S. E., Winters, K., Woodruff, P. G., Xanthakis, V., Zhang, Y., Zhang, Y., The C4R Investigators
10.1101/2021.03.19.21253986 — Posted: 2021-03-20
Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights
Nagy-Szakal, D., Couto-Rodriguez, M., Wells, H. L., Barrows, J. E., Debieu, M., Butcher, K. D., Chen, S., Berki, A. T., Hager, C. N., Boorstein, R. J., Taylor, M. K., Jonsson, C. B., Mason, C. E., O'Hara, N. B.
10.1101/2021.03.16.21252988 — Posted: 2021-03-20 Discussion: Onsite
SARS-CoV-2 show no infectivity at later stages in a prolonged COVID-19 patient despite positivity in RNA testing
Wan, X.-F., Tang, C. Y., Ritter, D., Wang, Y., Li, T., Segovia, K., Kosikova, M., Johnson, M., Kwon, H. J., Xie, H., Hammer, R. D., McElroy, J. A., Hamid, A., Collins, N. D., Hang, J., Camp, S.
10.1101/2021.03.18.21253228 — Posted: 2021-03-20
Evaluation of serum antibodies against SARS-CoV-2 in healthcare workers who participated in the operation of charter flights for the evacuation of Japanese residents from Hubei Province
Suzuki, T., Hayakawa, K., Ainai, A., Iwata-Yoshikawa, N., Sano, K., Nagata, N., Suzuki, T., Wakimoto, Y., Akiyama, Y., Miyazato, Y., Nakamura, K., Ide, S., Nomoto, H., Nakamoto, T., Ota, M., Moriyama, Y., Sugiki, Y., Saito, S., Morioka, S., Ishikane, M., Kinoshita, N., Kutsuna, S., Ohmagari, N.
10.1101/2021.03.17.21251964 — Posted: 2021-03-20
COVID-19 IN IRAQ, THE RURAL INITIATION (AL-MUTHANNA PROVINCE AS AN EXAMPLE)
Thwiny, H. T., Jaber, S. I., Ateya, H. K., Al-Yasari, A. M., Alsalih, N. J., AL- Saadawe, M. A., Jasim, E. S., Alsaadawi, M. A.
10.1101/2021.03.16.21251969 — Posted: 2021-03-20
Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine reported to EudraVigilance database
Tobaiqy, M., Elkout, H., MacLure, K.
10.1101/2021.03.19.21253980 — Posted: 2021-03-20 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).